Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis - Wikidata - wikimedia - TriplyDB

Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis

Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis

http://www.wikidata.org/entity/Q35630128

about

Pain management for rheumatoid arthritis and cardiovascular or renal co-morbidity Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity Cardiovascular risk assessment in rheumatoid arthritis - controversies and the new approach High-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammation Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis.The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study.Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis.Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study.A variant in the osteoprotegerin gene is associated with coronary atherosclerosis in patients with rheumatoid arthritis: results from a candidate gene study The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores.Urinary albumin excretion is increased in patients with rheumatoid arthritis and associated with arterial stiffness Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative.Increased prevalence of subclinical atherosclerosis in rheumatoid arthritis patients of Indian descent.Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis.Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis.Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis Rheumatoid arthritis and cardiovascular disease: an update on treatment issues.Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors.Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis Relation of Framingham risk score to subclinical atherosclerosis evaluated across three arterial sites.The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus.Drugs Used in the Treatment of Rheumatoid Arthritis: Relationship between Current Use and Cardiovascular Risk Factors.Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms.Association between Framingham risk score and subclinical atherosclerosis among elderly with both type 2 diabetes mellitus and healthy subjects.Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis.Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis.Ethnic differences in cardiovascular risk in rheumatic disease: focus on Asians.Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies.Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database.Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases.Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.Telomere Length and Coronary Atherosclerosis in Rheumatoid Arthritis Editorial: inflammation, disease-modifying antirheumatic drugs, lipids, and cardiovascular risk in rheumatoid arthritis.Psoriasis and the Framingham risk score in a Danish hospital cohort.Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes.Association between urinary sodium and potassium excretion and blood pressure and inflammation in patients with rheumatoid arthritis.

P2860

Q24235180-E215702E-FE2B-4778-8FF2-8B675981855A Q24235971-3109C108-8DDB-4D08-BA15-E83D9246F002 Q26738461-07665A90-FAF3-47B7-8036-AE22921E465E Q28480869-A2D07828-DD56-4125-8BC0-DBCF20AC4DEA Q33686973-8110F07E-575D-406F-BF0D-7805213F45A3 Q33848290-3F554349-FF23-4592-96FE-216B58AA90BA Q33943374-01A734E3-0D00-40CC-B7D1-D19D72833BCC Q34037325-E309AE6C-217F-424E-9AD6-C504939C059D Q34044918-6D4DE786-D718-4623-9480-C3472D2D7167 Q34614038-6E3F14AD-1D43-4101-B9E5-6BEA18868D0D Q35139150-CA2C4780-C3A1-4A17-8BA5-357ACFB35F2B Q35204645-9BF1974C-7B76-4737-BC74-9737D4D4B102 Q35251472-EF7CEAB7-236A-4803-8753-DD96A3420840 Q35652911-6C2E4270-9218-4C00-8031-80B4C2689953 Q36001551-A40EB01F-E470-4806-B840-0EDCF829AC1B Q36058974-57C85264-4CE8-4C40-BD70-6D5D64FC9E83 Q36117792-E185AB84-8C07-40E2-974F-D30AE7A39E07 Q36464352-7C857501-6982-4822-B8EA-850228D661D1 Q36511541-FD9D73E0-0409-444C-A56E-CF9CA77FDA2E Q36812587-ED0F2B54-BB40-47E0-8DC1-42A780E13119 Q36951050-23BD21AA-D0DC-40C8-96ED-042754141AFD Q36984426-27A0DFCC-8E9A-4977-B9A0-8DF059052724 Q37111710-3A7B3926-C714-466C-9F15-53D608FC511E Q37206876-6D0474EC-829F-43C5-8DF5-C8645FC1188B Q37292191-94266359-B026-40D9-BAA6-ADC78E983393 Q37300823-14A2BCB0-761F-425A-B24D-81A9E362C644 Q37371379-8D142255-5115-4A3C-8253-652CF59B9AE4 Q37587306-4E8AFB61-811F-4563-8C38-97C6CC0BC371 Q37765620-403E2842-A3E7-4BB5-A65C-4E51CB88CEEA Q37859678-5CE6E6ED-0436-4D05-AE9D-2392B3D035A6 Q37930979-E63104C3-464B-438E-9633-71CF44296E39 Q38026796-C853723C-5E52-4C95-B211-1092DBD0E634 Q38653041-F0631BD8-A949-4AB9-A2CF-4D2C85DADBEB Q38858035-F4933EAF-6E13-4732-B17E-CF0606D10D11 Q41728784-E8B3AAF6-B7A6-4C01-9BF1-3480C99F5B3A Q42385423-81DDF8BF-54B2-4161-9DDC-8CECD56671C3 Q43524523-E0A3DDB6-B7A9-4DB0-8A19-385E519E7DE9 Q45717444-B5710B38-E892-4183-8A43-5F54A318E27C Q46158768-5068CC29-1150-4A27-B7C2-9897808E5890 Q48263351-AEC7C7F3-B4D3-4AFA-910D-A83B1AE99D20

P2860

Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis

http://www.wikidata.org/entity/Q35630128

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Utility of the Framingham risk ...... ents with rheumatoid arthritis

@ast

Utility of the Framingham risk ...... ents with rheumatoid arthritis

@en

type

label

Utility of the Framingham risk ...... ents with rheumatoid arthritis

@ast

Utility of the Framingham risk ...... ents with rheumatoid arthritis

@en

prefLabel

Utility of the Framingham risk ...... ents with rheumatoid arthritis

@ast

Utility of the Framingham risk ...... ents with rheumatoid arthritis

@en

P1433

Q35630128-BACA549B-F60E-46BA-ABAC-71D1B96A3077

P1476

Q35630128-7DF3A306-7AF4-4677-A7C7-1EF06B61E2D0

P2093

Q35630128-0C52DCAC-DC63-4B9A-8CFB-E4311311DC3D

Q35630128-105BBEBC-4E9B-43A1-9D7B-051B5105371C

Q35630128-3B60391E-A3B2-40E5-8DDB-7C0053472F31

Q35630128-62D7F162-39EE-4601-8163-06D29F978143

Q35630128-B9378068-7BB7-41A5-A9DA-5757718BCA19

Q35630128-E3DE8625-89BB-4502-9C0A-13182FDD6669

Q35630128-F87BB86A-4784-423D-B898-FF404258AFB5

P2860

Q35630128-0B9413EA-E6CA-4258-BDC6-F9A698D8F498

Q35630128-0C54090F-4AF7-447E-9C25-CCB5300EAF9F

Q35630128-295E47B4-EB6E-49B1-B878-CE5E6E6AA86C

Q35630128-3E9BBF9B-49B8-4F20-A4DE-5F1501CFBD77

Q35630128-3F1E51EB-2635-4548-9129-3F497B4802A2

Q35630128-4C3D7340-5282-4B01-952F-D480479DF56C

Q35630128-61890D02-8C25-486B-8D40-2509F24C6572

Q35630128-618E5A84-CF70-4F12-AABC-82E04DB24474

Q35630128-6BC3B440-7BE6-42AD-A10F-9C1737F33BDD

Q35630128-82F283EB-2438-4A18-9F35-6FF6DE38E786

P2888

Q35630128-D3FA9F78-D1B0-44EA-9041-7E6AE0615047

P304

Q35630128-62811291-0C60-4E90-8236-E6FBB31BDDAB

P31

Q35630128-D6C4090E-51B7-4F71-9673-2A3CAD8773AF

P356

Q35630128-3356B0E5-19E0-4DC7-A301-C64F5C6D1090

P433

Q35630128-491A943A-4715-462D-B1B3-AC6AFE65524E

P478

Q35630128-9F5A6E4D-76EE-4454-8389-396A83EA674A

P50

Q35630128-43A97335-1EB8-4779-AA8F-B608ADD4D547

Q35630128-E3B89B47-1720-4D6B-B123-CA379E55885B

P577

Q35630128-42261490-8B38-4779-A8D2-62F9AAD1F69D

P5875

Q35630128-21896F26-4A8D-433A-90CB-B942C1C30F03

P6179

Q35630128-59C82359-61E3-4595-B911-CF0BD57F6000

P698

Q35630128-05FE5E22-A986-4251-B85A-76E42525E8CF

P921

Q35630128-541CF29E-D41E-4347-AB1A-F0259A0B35CC

Q35630128-F6F659E6-5422-443A-AE4C-1409920F08D7

P932

Q35630128-8B5A9342-254B-4353-97B1-2BDB610BFC58

P356

P1433

Arthritis Research and Therapy

P1476

Utility of the Framingham risk ...... ents with rheumatoid arthritis

@en

P2093

Annette Oeser

http://www.w3.org/2001/XMLSchema#string

Ayumi Shintani

http://www.w3.org/2001/XMLSchema#string

C Michael Stein

http://www.w3.org/2001/XMLSchema#string

Cecilia P Chung

http://www.w3.org/2001/XMLSchema#string

Ingrid Avalos

http://www.w3.org/2001/XMLSchema#string

Paolo Raggi

http://www.w3.org/2001/XMLSchema#string

Tuulikki Sokka

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Coronary age as a risk factor in the modified Framingham risk score

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Cardiovascular risk factors in women with and without rheumatoid arthritis

''R"--project for statistical computing

Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations.

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Taking mortality in rheumatoid arthritis seriously--predictive markers, socioeconomic status and comorbidity.

Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

P2888

P304

R186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR2098

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Theodore Pincus

Tebeb Gebretsadik

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6631168

http://www.w3.org/2001/XMLSchema#string

P6179

1032169306

http://www.w3.org/2001/XMLSchema#string

P698

17169159

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

1794532

http://www.w3.org/2001/XMLSchema#string